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Abstract
Background: Radiation therapy is a mainstay in the treatment of esophageal cancer (EC) patients, and photon
radiotherapy has proved beneficial both in the neoadjuvant and the definitive setting. However, regarding the still
poor prognosis of many EC patients, particle radiation employing a higher biological effectiveness may help to
further improve patient outcomes. However, the influence of clinically available particle radiation on EC cells
remains largely unknown.
Methods: Patient-derived esophageal adenocarcinoma and squamous cell cancer lines were treated with photon
and particle irradiation using clinically available proton (1H), carbon (12C) or oxygen (16O) beams at the Heidelberg
Ion Therapy Center. Histology-dependent clonogenic survival was calculated for increasing physical radiation doses,
and resulting relative biological effectiveness (RBE) was calculated for each radiation modality. Cell cycle effects
caused by photon and particle radiation were assessed, and radiation-induced apoptosis was measured in
adenocarcinoma and squamous cell EC samples by activated caspase-3 and sub-G1 populations. Repair kinetics of
DNA double strand breaks induced by photon and particle radiation were investigated.
Results: While both adenocarcinoma EC cell lines demonstrated increasing sensitivities for 1H, 12C and 16O
radiation, the two squamous cell carcinoma lines exhibited a more heterogeneous response to photon and particle
treatment; average RBE values were calculated as 1.15 for 1H, 2.3 for 12C and 2.5 for 16O irradiation. After particle
irradiation, squamous cell EC samples reacted with an increased and prolonged block in G2 phase of the cell cycle
compared to adenocarcinoma cells. Particle radiation resulted in an incomplete repair of radiation-induced DNA
double strand breaks in both adenocarcinoma and squamous cell carcinoma samples, with the levels of initial
strand break induction correlating well with the individual cellular survival after photon and particle radiation.
Similarly, EC samples demonstrated heterogeneous levels of radiation-induced apoptosis that also corresponded to
the observed cellular survival of individual cell lines.
Conclusions: Esophageal cancer cells exhibit differential responses to irradiation with photons and 1H, 12C and 16O
particles that were independent of tumor histology. Therefore, yet unknown molecular markers beyond histology
may help to establish which esophageal cancer patients benefit from the biological effects of particle treatment.
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Introduction
Esophageal cancer (EC) affects more than 450,000 patients
globally per year and is associated with a dismal prognosis
[1]. The main histological subtypes of EC are adenocarcin-
omas (AC) and squamous cell carcinomas (SCC) with
different etiologic factors and regional incidence patterns
[1]. The current standard of care encompasses local treat-
ments for early stage EC, often preceded by neoadjuvant
therapies and multimodality treatment approaches for
more frequently diagnosed locally advanced EC [2]. Des-
pite recent advances in EC management, prognosis re-
mains poor with estimated 5-year overall survival rates
ranging between 15 to 20% [3]. Conventional photon
radiotherapy (RT) is a key treatment modality for EC pa-
tients and is used both in the neoadjuvant and definitive
setting, often in combination with systemic treatments
[4–7]. Due to mediocre local control rates resulting in dis-
mal patient outcome and potential severe RT-associated
morbidity, there is a strong demand for improvements in
RT approaches [8–10].
In contrast to conventional photon radiotherapy, par-
ticle RT offers several promising physical and biological
characteristics that may be of benefit for EC patients.
Charged particles exhibit an inverse dose-depth profile
that allows a deposition of high radiation doses in a pre-
defined target area (Bragg peak) while sparing surround-
ing healthy tissues and organs at risk. Additionally,
particle RT is characterized by a higher linear energy
transfer (LET) and hence an increased relative biological
effectiveness compared to conventional photon RT de-
pending on the atomic mass of the used particles and
the target cells [11–13]. The higher LET leads to more
densely spaced and complex DNA damage, especially
irreparable DNA double-strand breaks that helps to
overcome hypoxia-associated relative radiation resist-
ance often seen in larger tumors [12]. Clinical benefits of
particle beam RT have been demonstrated for several
tumor entities [14–17]. However, the influence and po-
tential benefits of particle RT on EC remain largely
unexplored both in vitro and in the clinical setting, and
the benefits for EC patients are unknown.
The aim of this study was to systematically evaluate
the in-vitro effects of clinically available charged parti-
cles on the survival, damage response and DNA repair
of EC cell lines of different histologies in comparison
with photon RT.
Materials and methods
Cell culture
The human esophageal AC cell lines OE19 and OE33
and the human esophageal SCC lines KYSE270 and
KYSE410 were purchased from the European Collection
of Authenticated Cell Cultures (ECAAC, Public Health
England, Salisbury, UK). OE19, OE33 and KYSE410 cells
were cultured in RPMI1640 medium (Biochrom, Berlin,
Germany), supplemented with 5% fetal bovine serum (Bio-
chrom) and 1% penicillin-streptomycin (Thermo Fisher
Scientific, Dreieich, Germany). KYSE270 cells were grown
in 1:1 Ham’s F-12 (Biochrom) and RPMI1640 medium
with the addition of 2% fetal bovine serium and 1%
penicillin-streptomycin. Cells were maintained in a hu-
midified incubator at 37 °C and 5% CO2.
Radiation treatments
Photon (X) irradiation was performed with a linear ac-
celerator (XRAD 320, Precision X-Ray, North Branford,
USA) using single doses ranging between 2 and 10 Gy at
320 kV and a dose rate of 1 Gy/min. Proton (1H), carbon
(12C) and oxygen (16O) ion irradiation was performed at
the Heidelberg Ion Therapy Center using the raster-
scanning technique with a spread-out Bragg peak of
35 ± 5 mm. Energy levels and linear energy transfer
for 1H, 12C and 16O irradiation were 64.1–70MeV/u
and 6 keV/μm, 122.4–136,9 MeV/u and 101 keV/ μm,
141.4–160.9 MeV/u and 154 keV/ μm, respectively.
Clonogenic survival assays
Cells were plated in cell culture flasks and left to attach for
at least 6 h before irradiation. Cell numbers were adjusted
depending on radiation quality and dose (OE19: 400–8000,
OE33: 400–8000, KYSE270: 500–9000, KYSE410: 300–
4000). After treatment, the cells were maintained for 10 to
14 days to allow cells to form colonies. Colonies were fixed
with 25% acetic acid (v/v) in methanol and stained with
crystal violet solution. Colonies with more than 50 cells
were then counted by light microscopy. For each cell
line and condition three independent experiments
were performed with three replicate samples. The
surviving fraction of cells was calculated based on the
following formula: (#colonies/#plated cells)treated/(#col-
onies/#plated cells)untreated. Replicate samples were aver-
aged and the mean and standard deviation (SD) of all
independent experiments was plotted against radiation
dose. Survival curves were fitted according to the
linear-quadratic model and used to calculate the rela-
tive biological effectiveness (RBE) according to the
formula: (photon dose)10% survival/(experimental irradi-
ation dose)10% survival.
Flow Cytometry
Cells were plated in triplicates 12 h prior to irradiation
with biologically equivalent doses (2 and 8 Gy for X and
1H, 1 and 3 Gy for 12C and 16O) according to the mean
RBE value of each irradiation modality. After 2, 8, 24, 48
and 96 h the cells were harvested using trypsin/ethylene-
diaminetetraacetic acid, fixed with paraformaldehyde
and permeabilized with ice-cold 70% ethanol. The sam-
ples were washed three times with 0.5% bovine serum
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albumin (BSA) in PBS and then incubated with anti-
bodies diluted in 3% BSA/PBS for 1 h as follows: The 2
and 8 h samples were incubated with 1:20 diluted Alexa
Fluor-488-coupled antibody against γH2AX (BioLegend,
San Diego, USA), the 48 and 96 h samples were incubated
with 1:20 diluted Alexa Fluor-647-coupled antibody
against active caspase-3 (Becton Dickinson, Heidelberg,
Germany) and the 24 h samples were incubated with both
antibodies at the same dilutions. All samples were then
stained with 1 μg/mL DAPI (Sigma Aldrich, Taufkirchen,
Germany) in PBS and measured with a LSRII flow cyt-
ometer (Beckton-Dickinson), recording 10,000 events per
sample. Data analysis was performed with FlowJo 7.6.5
software (LLC, Ashland, USA) as reported before [18, 19].
Cells were gated (front scatter vs. side scatter plot) to ex-
clude debris and cell doublets/aggregates were filtered out
(DAPI-A vs. DAPI-W plot). The DAPI-A histogram of
single cells was used to gate subG1 cells vs. cells with nor-
mal DNA content and to further classify the latter popula-
tion into different cell cycle stages using the Dean-Jett-Fox
model. G1, S and G2/M cells were gated for cell cycle-
specific γH2AX measurement (DAPI-A vs. DAPI-W plot).
For each population, the median γH2AX intensity was cal-
culated and the following formula was used to calculate
the combined γH2AX levels in the whole cell population
(corrected for cell cycle-specific DNA content): IA = IG1 *
G1 + (IS * S) / 1.5 + (IG2|M * G2|M) / 2, where IA, IG1, IS,
IG2|M are median γH2AX intensities of all, G1, S, G2/M
cells respectively and G1, S, G2|M are the frequencies of
cells in the respective cell cycle phase. The median
γH2AX levels of each population was divided by the aver-
age of the controls for normalization. For apoptosis meas-
urement both the percentage of subG1-positive and active
caspase-3-positive cells were gated in the single cell popu-
lation and subtracted from the average control levels. All
experiments were performed with three replicate samples.
Statistical analyses
Statistical comparison of data was performed by two-
sided Student’s t-tests using SPSS Statistics 25 software
(IBM, Ehningen, Germany). These tests were paired for
comparisons of clonogenic survival data between differ-
ent radiation modalities or between different cell lines.
All described data represent mean values and SD.
Results
Oesophageal cancer cell lines show heterogeneous
radiation responses to particle irradiation
Individual sensitivities of AC cell lines OE19 and OE33
and SCC cell lines KYSE270 and KYSE410 to particle radi-
ation were assessed by clonogenic survival assays. Survival
curves after exposure to conventional photon radiation
were comparable for OE19, KYSE270 and KYSE410, while
OE33 were markedly more sensitive, as demonstrated by a
significantly stronger dose-dependent decrease in clono-
genic survival (p = 0.001 for OE33 vs. OE19, p = 0.54 for
OE33 vs. KYSE270, p < 0.001 for OE33 vs. KYSE410, two-
sided paired Student’s t-test, (Additional file 1: Figure S1).
For the AC cell lines OE19 and OE33, clonogenic survival
did not significantly differ after photon and 1H irradiation
(p = 0.09 for OE19, p = 0.89 for OE33, Fig. 1), whereas
treatment with 12C and 16O particles resulted in signifi-
cantly reduced survival in both cell lines compared to
photon radiation (12C vs. X: p = 0.004 for OE19, p = 0.002
for OE33; 16O vs. X: p = 0.003 for OE19, p = 0.001 for
OE33). The tested SCC cell lines showed considerable het-
erogeneity regarding their response to photon and particle
irradiation: KYSE270 presented the highest sensitivities
towards all particle irradiation modalities compared to
photon treatment (p = 0.005 for 1H vs. X; p = 0.002 for 12C
vs. X; p = 0.005 for 16O vs. X), while there were only mar-
ginal survival differences after photon and particle irradi-
ation in KYSE410 cells (p = 0.82 for 1H vs. X; p = 0.65 for
12C vs. X; p = 0.01 for 16O vs. X). Resulting average RBE
values at 10% survival were 1.15 for 1H vs. X, 2.3 for 12C
vs. X and 2.5 for 16O vs. X (Fig. 1).
Particle irradiation results in a prolonged block in the G2
phase of the cell cycle
Flow cytometric analyses were performed to assess dif-
ferential effects of photon and particle irradiation on the
cell cycle of esophageal AC and SCC samples. For com-
parison, the cells were irradiated with isoeffective doses
of photon, 1H, 12C or 16O radiation at a low dose level
(X: 2 Gy, 1H: 2 Gy, 12C: 1 Gy, 16O: 1 Gy) and a high dose
level (X: 8 Gy, 1H: 8 Gy, 12C: 3 Gy, 16O: 3 Gy). Unirradi-
ated controls were included to determine the cell cycle
distribution in unperturbed cells. Exposure to all radi-
ation modalities resulted in a strong and prolonged
block of esophageal cancer cell lines in the G2 phase of
the cell cycle at the high dose level. At the low dose
level, a pronounced G2 arrest was only observed in the
most sensitive cell line KYSE270 for all radiation modal-
ities and in OE19 and OE33 cells after particle irradiation.
In comparison to photons, 1H, 12C and 16O irradiation in-
duced a significantly stronger G2 arrest within 24 h in
both AC cell lines and at both dose levels (at the high dose
level X: 37%, 1H: 59%, 12C: 58%, 16O: 65% for OE19; X:
42%, 1H: 63%, 12C: 65%, 16O: 62% for OE33) (Fig. 2, Add-
itional file 2: Figure S2). This pronounced G2 phase block
slowly decreased, but persisted up to 96 h after particle ir-
radiation, while AC cells exposed to photon irradiation
returned to baseline levels within 96 h after treatment
(Additional file 3: Figure S3, Additional file 4: Figure S4).
In the SCC cell lines, a comparable to even stronger G2
phase block was observed at 24 h after treatment with ei-
ther radiation modality at the high dose level, but there
were no clear differences between photon and particle
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irradiation (X: 86%, 1H: 89%, 12C: 88%, 16O: 93% for
KYSE270; X: 77%, 1H: 72%, 12C: 74%, 16O: 77% for
KYSE410). In KYSE270 cells, the G2 block persisted
largely unchanged up to 48 h after treatment irrespect-
ive of the radiation modality at both dose levels, correl-
ating well with the generally high radiation sensitivity
observed in the clonogenic survival assays for these
cells. The more radioresistant KYSE410 cells demon-
strated a swift reduction of cells arrested in G2 phase at
24 h after both photon and particle treatment at the
low dose level, but a strong G2 arrest at the high dose
level. At 96 h after treatment, both SCC cell lines demon-
strated lower levels of G2 phase cells after photon (30%
for KYSE270, 27% for KYSE410) than after 1H, 12C or 16O
irradiation (1H: 48%, p = 0.092; 12C: 43%, p = 0.110; 16O:
42%, p = 0.038 for KYSE270; 1H: 42%, p = 0.008; 12C: 35%,
p = 0.112; 16O: 34%, p = 0.006 for KYSE410).
Photon and particle irradiation lead to heterogeneous
increases in apoptosis induction of esophageal cancer cells
Cellular caspase-3 activity and sub-G1 populations were
measured as indicators for early and late radiation-
induced apoptosis at 48 and 96 h after irradiation with
biologically isoeffective doses of photons, 1H, 12C and
16O particles. A time- and dose-dependent increase of
apoptosis induction was detected at 48 and 96 h for all
tested cell lines (Fig. 3, Additional file 5: Figures S5,
Additional file 6: Figure S6). While lower isoeffective
doses of 2 Gy photons and 1H and 1 Gy 12C and 16O re-
sulted in apoptosis induction in less than 5% of tested
cell lines, a time- and dose-dependent increase of apop-
tosis induction was detected at 48 and 96 h for the high
dose level. At 96 h after irradiation, comparable rates of
caspase-3-positive cells ranging between 28 and 35%
were found for all tested radiation modalities; however,
the average apoptotic sub-G1 population after photon
radiation amounted to 20% and was significantly higher
than after 1H (8%, p < 0.05), 12C (8%, p < 0.05) and 16O
radiation (7%, p < 0.05). Considerable heterogeneity re-
garding apoptosis induction was noted for the SCC cell
lines: KYSE270 demonstrated higher apoptosis levels after
12C (p < 0.05) and 16O (p < 0.01) irradiation than after
photon treatment as measured by caspase-3 activation,
whereas KYSE410 demonstrated lower apoptosis rates for
12C and 16O particle radiation compared to conventional
photons, although statistical significance was not reached
(p = 0,095 for 12C, p = 0,44 for 16O); this correlated well
with the clonogenic survival data observed after photon
and particle irradiation in these cell lines. The AC cell
lines did not exhibit a general difference in apoptosis
Fig. 1 Esophageal cancer cell lines show heterogeneous survival after photon and particle irradiation. Clonogenic survival curves of OE19 and
OE33 adenocarcinoma and KYSE270 and KYSE410 squamous cell carcinoma cell lines after photon (X), proton (1H), carbon ion (12C) and oxygen
ion (16O) irradiation (mean ± SD of 3 independent experiments). The table depicts the relative biological effectiveness (RBE) for 1H, 12C and 16O
radiation at 10% survival
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induction between photons and particle radiation. OE19
cells demonstrated higher levels of caspase-3 activation
after particle than after photon irradiation at 48 and 96 h
that were not reflected in the sub-G1 population of these
cells. In contrast, the sub-G1 population of OE33 cells
exhibited an increased sub-G1 population after photon ir-
radiation compared to particle treatment after 48 and 96 h
that was not mirrored in increased caspase-3 activation.
DNA double strand breaks induced by particle radiation
are incompletely repaired
Levels of the phosphorylated H2AX histone protein
(γH2AX) were measured in a cell cycle- specific way by
flow cytometry as a surrogate marker for radiation-
induced DNA double strand breaks. Photon irradiation
resulted in a swift increase of γH2AX peak levels within
2 h in all tested esophageal cancer cells (Fig. 4, Additional
files 7, 8, 9 and 10: Figures S7-S10). While γH2AX levels
returned to baseline after low photon doses of 2 Gy, indi-
cating complete repair of double strand breaks, peak levels
were found incompletely resolved after higher photon
doses of 8 Gy, indicating unrepaired radiation-induced
DNA damage. Similar γH2AX kinetics were observed
after 1H irradiation with high peak levels after 2 h and
incomplete resolution of H2AX phosphorylation within
24 h for all tested cell lines. For 12C radiation, a significant
decrease of γH2AX levels between 2 and 24 h was only
measured for OE19 cells, while all other cell lines exhib-
ited no significant reduction of peak γH2AX levels, sug-
gesting negligible repair of radiation-induced damage.
Comparable lack of DNA double strand break repair was
observed after 16O irradiation for all esophageal cell lines.
Of note, KYSE410 cells continuously exhibited the lowest
γH2AX levels at 2 h after irradiation, most likely indicat-
ing very efficient DSB repair already within this rather
short time period, corresponding to their pronounced
resistance to both photon and particle irradiation.
Discussion
Here, we demonstrated for the first time the differential
effects of photon and particle irradiation on esophageal
cancer cell lines of different histologies regarding cellular
Fig. 2 Particle irradiation results in a prolonged block in the G2 phase. Percentage of cells in G2/M phase of four EC cell lines at 24 h after
irradiation with biologically isoeffective doses of photons (X), protons (1H) and heavy ions (12C, 16O) at a low dose level (left bars) and a high dose
level (right bars) (mean and SD of n = 3 replicate samples). For clarity the low dose and high dose data is shown separately; the control groups
are identical in both parts because for each radiation modality both dose levels were applied in the same experiment with one common control
group per time point. *p < 0.05, **p < 0.01 (two-sided Student’s t-test between the indicated groups). For test comparing different radiation
modalities were the control levels were subtracted from the
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survival, apoptosis induction and DNA double strand
break repair.
Clinically available ion beam radiation with protons or
heavier ions like 12C or 16O may make use of the parti-
cles’ physical advantages like their inverted dose-depth
profile, resulting in the ability to increase treatment
doses while sparing surrounding organs-at-risk, or their
increased RBE values. Indeed, in our dataset, the RBE
values for 12C and 16O radiation were determined to be
2.3 and 2.5, respectively. These values compare well with
previous RBE calculations of 12C irradiation obtained
from animal models that have suggested values around
2.0 compared to photon irradiation [18, 19]. No data
have been published yet concerning RBE values of par-
ticle radiation using heavier ions such as 16O radiation
in esophageal cancer.
We found significant differences in cellular sensitivities
to photon and particle radiation in the two human
esophageal SCC cell lines tested, while the survival data
were more consistent for the 2 AC cell lines. Histology-
dependent radiation responses have been widely re-
ported for esophageal cancer not only in vitro, but
even in patients undergoing clinical radiation therapy
[4, 20, 21]. Esophageal SCC is known to be more ra-
diosensitive compared to AC, resulting in a higher rate
of pathological complete response (pCR) after neoadju-
vant chemoradiotherapy. Albeit pCR rate is higher for
esophageal SCC, both SCC and AC esophageal cancer
benefit from preoperative chemoradiotherapy. However,
factors beyond tumor histopathology may strongly in-
fluence radiation responses of individual esophageal
cancers not only to photon but especially particle radi-
ation, and indeed, our data suggest a strong heterogen-
eity of RBE values that were not histology-specific: RBE
values for 12C and 16O radiation ranged between 0.7
and 4.3 and 0.8 and 5.0, respectively, with the SCC cell
lines exhibiting both the most radioresistant and radio-
sensitive phenotypes.
Fig. 3 Particle irradiation leads to heterogeneous increases in apoptosis induction of esophageal cancer cells. Percentage of apoptotic EC cells
accessed by the sub-G1 fraction and cellular caspase-3 activation measured at 96 h after irradiation with biologically isoeffective doses of photons
(X), protons (1H) and heavy ions (12C, 16O) (mean and SD of n = 3 replicate samples). *p < 0.05, **p < 0.01 (two-sided Student’s t-test against
unirradiated controls)
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Surprisingly, OE33 cells were observed to be more re-
sistant to photon compared to proton irradiation. Add-
itionally, KYSE410 exhibited similar clonogenic survival
curves for 1H, 12C and 16O radiation. Resistance to pro-
ton and particle irradiation is linked to effective homolo-
gous recombination (HR) DSB repair, and previous
studies have shown the important role of HR for esopha-
geal AC and SCC such as OE33 and KYSE410 [22–25].
However, further studies are needed to elucidate the
mechanisms for the increased resistance to proton and
particle irradiation in these cell lines.
All tested types of particle irradiation resulted in in-
complete repair of radiation-induced DNA double
strand breaks, correlating with a prolonged G2 phase ar-
rest. Cell cycle arrests are usually signs of ongoing at-
tempts of the cell to repair life-threatening DNA lesions
such as DSBs, but are not necessarily predictive for the
success of DNA repair. Previous publications have dem-
onstrated correlations of residual γH2AX signals detect-
able beyond 24 h after irradiation with both increased
radiation sensitivity and increased DNA repair capacity
[26–28]. In line with these reports, both the radiosensi-
tive KYE270 and the strongly resistant KYSE410 cell
lines were found to exhibit strong increases in G2 phase
cells with elevated γH2AX levels at 24 h after treatment
in our dataset. Additionally, response to particle irradi-
ation was found to correlate with the level of apoptosis
induction in all tested esophageal cancer samples, and
the cell lines most sensitive to 12C and 16O irradiation
exhibited the highest levels of caspase-3 induction at 96
h after treatment. Interestingly, caspase-3 activation was
higher after 12C and 16O irradiation versus photons in
OE19 and KYSE270 cells, despite of isoeffective dosage,
while only marginal differences were observed in OE33
cells and slightly smaller levels were seen for KYSE410
cells irradiated with 12C and 16O versus X and 1H. These
variations might indicate that other types of cell death
contribute to the overall cell killing effect in a cell line-
and radiation modality-dependent manner. Previous re-
ports have outlined a correlation between the induction
of apoptosis and the response of esophageal cancer cells
and patients to radiation therapy [29–31]. However, it
remains unclear if apoptosis levels are linked to the
prognostic rates of pathological complete remission after
irradiation. Considering the increased biological effect-
iveness of particle irradiation, especially with heavier 12C
Fig. 4 Esophageal cancer cells incompletely repair DNA double strand breaks induced by particle irradiation. Normalized γH2AX levels at 2 and
24 h after irradiation with biologically isoeffective doses of photons (X), protons (1H) and heavy ions (12C, 16O) (mean and SD of n = 3 replicate
samples). Values were corrected for cell cycle-specific differences as detailed in Materials and Methods. *p < 0.05, **p < 0.01 (two-sided Student’s t-
test against unirradiated controls)
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or 16O beams and the superior physical dose distribution
of these particle treatments, it is conceivable that dis-
tinct patient subgroups may derive a clinical benefit
from 12C or 16O-based radiation therapy. However, the
identification of these patient subgroups does not seem to
rely on the histology, and additional molecular markers and
signatures are warranted to define the individual benefit of
each patient to this novel treatment. While this analysis in-
vestigated the use of particle radiation alone on esophageal
cancer cells in order to quantify the biological effects,
clinical treatment algorithms rely on the combination of ra-
diation with systemic treatments including potentially
radiosensitizing anti-cancer drugs such as platinum com-
pounds, 5-fluorouracil or paclitaxel [4, 6, 32]. Therefore,
combination treatments remain to be investigated in order
to establish a potential use of particle irradiation in clinic-
ally established chemo-radiotherapy protocols.
Conclusions
Taken together, we demonstrated a differential sensitivity
of esophageal cancer cells to irradiation with photons
and 1H, 12C and 16O particles that was independent of
tumor histology. Considering the vastly different re-
sponses of esophageal cancer samples to particle irradi-
ation, yet unknown molecular markers may help to
establish which esophageal cancer patients may benefit
from particle treatments.
Additional files
Additional file 1: Figure S1. Survival curves after exposure to photon
irradiation. Linear-quadratic fits of clonogenic survival data from OE19
and OE33 adenocarcinoma and KYSE270 and KYSE410 squamous cell
carcinoma cell lines after photon. (TIF 449 kb)
Additional file 2: Figure S2. Particle irradiation results in a prolonged
block in the G2 phase. Cell cycle profiles of four EC cell lines at 24 h after
irradiation with biologically isoeffective doses of photons (X), protons (1H)
and heavy ions (12C, 16O) (mean and SD of n = 3 replicate samples).
*p < 0.05, **p < 0.01 (two-sided Student’s t-test against unirradiated
controls). (TIF 701 kb)
Additional file 3: Figure S3. G2 phase arrest at 48 h after particle
irradiation. Cell cycle distribution of EC cell lines at 48 h after irradiation
with biologically isoeffective doses of photons (X), protons (1H) and
heavy ions (12C, 16O) (mean and SD of n = 3 replicate samples).*p < 0.05,
**p < 0.01 (two-sided Student’s t-test against unirradiated controls).
(TIF 699 kb)
Additional file 4: Figure S4. G2 phase arrest at 96 h after particle
irradiation. Cell cycle distribution of EC cell lines at 96 h after irradiation
with biologically isoeffective doses of photons (X), protons (1H) and
heavy ions (12C, 16O) (mean and SD of n = 3 replicate samples). *p < 0.05,
**p < 0.01 (two-sided Student’s t-test against unirradiated controls).
(TIF 702 kb)
Additional file 5: Figure S5. Apoptosis induction in different
esophageal cancer cell lines at 24 h after treatment with different
radiation modalities. Percentage of apoptotic EC cells as accessed by the
sub-G1 fraction and cellular caspase-3 activity at 24 h after irradiation with
biologically isoeffective doses of photons (X), protons (1H) and heavy ions
(12C, 16O) (mean and SD of n = 3 replicate samples). *p < 0.05, **p < 0.01
(two-sided Student’s t-test against unirradiated controls). (TIF 586 kb)
Additional file 6: Figure S6. Particle irradiation induces varying levels
of apoptosis in different esophageal cancer cell lines at 48 h after
irradiation. Percentage of apoptotic EC cells as accessed by the sub-G1
fraction and cellular caspase-3 activity at 48 h after irradiation with
biologically isoeffective doses of photons (X), protons (1H) and heavy ions
(12C, 16O) (mean and SD of n = 3 replicate samples). *p < 0.05, **p < 0.01
(two-sided Student’s t-test against unirradiated controls). (TIF 613 kb)
Additional file 7: Figure S7. Induction and repair of DNA double
strand breaks in G1 phase cells after irradiation. Normalized γH2AX levels
of G1 phase cells at 2, 8 and 24 h after irradiation with biologically
isoeffective doses of photons (X), protons (1H) and heavy ions (12C, 16O)
(mean and SD of n = 3 replicate samples). *p < 0.05, **p < 0.01 (two-sided
Student’s t-test against unirradiated controls). (TIF 592 kb)
Additional file 8: Figure S8. Induction and repair of DNA double
strand breaks in S phase cells after irradiation. Normalized γH2AX levels of
S phase cells at 2, 8 and 24 h after irradiation with biologically isoeffective
doses of photons (X), protons (1H) and heavy ions (12C, 16O) (mean and
SD of n = 3 replicate samples). *p < 0.05, **p < 0.01 (two-sided Student’s
t-test against unirradiated controls). (TIF 570 kb)
Additional file 9: Figure S9. Induction and repair of DNA double
strand breaks in G2 phase cells after irradiation. Normalized γH2AX levels
of G2 phase cells at 2, 8 and 24 h after irradiation with biologically
isoeffective doses of photons (X), protons (1H) and heavy ions (12C, 16O)
(mean and SD of n = 3 replicate samples). *p < 0.05, **p < 0.01 (two-sided
Student’s t-test against unirradiated controls). (TIF 568 kb)
Additional file 10: Figure S10. Induction and repair of DNA double
strand breaks in esophageal cancer cells after irradiation. γH2AX levels
(not normalized) at 2 and 24 h after irradiation with biologically
isoeffective doses of photons (X), protons (1H) and heavy ions (12C, 16O)
(mean and SD of n = 3 replicate samples). Values were corrected for cell
cycle-specific differences as detailed in Materials and Methods. *p < 0.05,
**p < 0.01 (two-sided Student’s t-test against unirradiated controls).
(TIF 602 kb)
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